In case of FACBC, in vitro studies on prostate cancer and glioma indicated that the alanine-serine-cysteine transporters (ASCT), especially ASCT2, and L-type amino acid transporters (LAT), especially LAT1, are involved in its uptake (14-16). This evidence concerns the gene LAT and central nervous system cancer.